Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Claudio Micheletto, Fulvio Braido, Marco Contoli, Fabiano Di Marco & Pierachille Santus. (2019) A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2185-2193.
Read now
Read now
Anthony D D’Urzo, Peter Kardos & Russell Wiseman. (2018) Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1089-1104.
Read now
Read now
Amnon Ariel, Alan Altraja, Andrey Belevskiy, Piotr W Boros, Edvardas Danila, Matjaz Fležar, Vladimir Koblizek, Zvi G Fridlender, Kosta Kostov, Alvils Krams, Branislava Milenkovic, Attila Somfay, Ruzena Tkacova, Neven Tudoric, Ruxandra Ulmeanu & Arschang Valipour. (2018) Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 45-56.
Read now
Read now
Brian W. Carlin, Sandra K. Schuldheisz, Imre Noth & Gerard J. Criner. (2017) Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care. Postgraduate Medicine 129:7, pages 725-733.
Read now
Read now
Didier Cataldo, Jean-Louis Corhay, Eric Derom, Renaud Louis, Eric Marchand, Alain Michils, Vincent Ninane, Rudi Peché, Charles Pilette, Walter Vincken & Wim Janssens. (2017) A Belgian survey on the diagnosis of asthma–COPD overlap syndrome. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 601-613.
Read now
Read now
Elena Visentin, Dario Nieri, Barbara Vagaggini, Elena Peruzzi & Pierluigi Paggiaro. (2016) An observation of prescription behaviors and adherence to guidelines in patients with COPD: real world data from October 2012 to September 2014. Current Medical Research and Opinion 32:9, pages 1493-1502.
Read now
Read now
Pavlina A. Andreeva-Gateva, Eleonora Stamenova & Tzvetelin Gatev. (2016) The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review. Postgraduate Medicine 128:5, pages 474-484.
Read now
Read now
Hiroshi Chantaphakul & Kiat Ruxrungtham. (2016) Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma. Expert Opinion on Pharmacotherapy 17:5, pages 631-642.
Read now
Read now
Articles from other publishers (21)
Mònica Monteagudo, Alexa Nuñez, Miriam Barrecheguren & Marc Miravitlles. (2022) Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study. Archivos de Bronconeumología 58:10, pages 699-707.
Crossref
Crossref
Ian M. Adcock, Surya P. Bhatt, Ronald Balkissoon & Robert A. Wise. (2022) The Use of Inhaled Corticosteroids for Patients with COPD Who Continue to Smoke Cigarettes: An Evaluation of Current Practice. The American Journal of Medicine 135:3, pages 302-312.
Crossref
Crossref
Helgo Magnussen, Sarah Lucas, Therese Lapperre, Jennifer K. Quint, Ronald J. Dandurand, Nicolas Roche, Alberto Papi, David Price & Marc Miravitlles. (2021) Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study. Respiratory Research 22:1.
Crossref
Crossref
Jonathan C. Weissler & Traci N. Adams. (2021) Eosinophilic Chronic Obstructive Pulmonary Disease. Lung 199:6, pages 589-595.
Crossref
Crossref
James D. Chalmers, Irena F. Laska, Frits M.E. Franssen, Wim Janssens, Ian Pavord, David Rigau, Melissa J. McDonnell, Nicolas Roche, Don D. Sin, Daiana Stolz, Samy Suissa, Jadwiga Wedzicha & Marc Miravitlles. (2020) Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline. European Respiratory Journal 55:6, pages 2000351.
Crossref
Crossref
Daiana Stolz & Marc Miravitlles. (2020) The right treatment for the right patient with COPD: lessons from the IMPACT trial. European Respiratory Journal 55:5, pages 2000881.
Crossref
Crossref
Brianna Atto, Mathew Suji Eapen, Pawan Sharma, Urs Frey, Alaina J. Ammit, James Markos, Collin Chia, Josie Larby, Greg Haug, Heinrich C. Weber, George Mabeza, Stephen Tristram, Stephen Myers, Dominic P. Geraghty, Katie L. Flanagan, Philip M. Hansbro & Sukhwinder Singh Sohal. (2019) New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways. Clinical Science 133:14, pages 1663-1703.
Crossref
Crossref
Antonio Anzueto & Marc Miravitlles. (2018) Considerations for the Correct Diagnosis of COPD and Its Management With Bronchodilators. Chest 154:2, pages 242-248.
Crossref
Crossref
M. Miravitlles. (2018) Diagnosis of asthma-COPD overlap: Is it possible a global definition?. Pulmonology 24:3, pages 143-145.
Crossref
Crossref
Marc Miravitlles, Seungjae BaekVatsal VithlaniRahul Lad. (2018)
Optimal Bronchodilation for COPD Patients: Are All Long-Acting β
2
-Agonist/Long-Acting Muscarinic Antagonists the Same?
. Tuberculosis and Respiratory Diseases 81:3, pages 198.
Crossref
Crossref
Marc Miravitlles, Borja G. Cosío, Aurelio Arnedillo, Myriam Calle, Bernardino Alcázar-Navarrete, Cruz González, Cristóbal Esteban, Juan Antonio Trigueros, José Miguel Rodríguez González-Moro, José Antonio Quintano Jiménez & Adolfo Baloira. (2017) A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease. Respiratory Research 18:1.
Crossref
Crossref
Sarah E. Petite. (2017)
Role of Long-Acting Muscarinic Antagonist/Long-Acting β
2
-Agonist Therapy in Chronic Obstructive Pulmonary Disease
. Annals of Pharmacotherapy 51:8, pages 696-705.
Crossref
Crossref
Jia-Xi Feng, Yun Lin, Jian Lin, Su-Su He, Mei-Fang Chen, Xiao-Mai Wu & You-Zu Xu. (2017) Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity. Journal of Korean Medical Science 32:3, pages 439.
Crossref
Crossref
Edward Kerwin. (2016) A new alphabet for COPD care. European Respiratory Journal 48:4, pages 972-975.
Crossref
Crossref
David B. Price, Richard Russell, Rafael Mares, Anne Burden, Derek Skinner, Helga Mikkelsen, Cherlyn Ding, Richard Brice, Niels H. Chavannes, Janwillem W. H. Kocks, Jeffrey W. Stephens & John Haughney. (2016) Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study. PLOS ONE 11:9, pages e0162903.
Crossref
Crossref
Jun-Jun Yeh, Yu-Chiao Wang & Chia-Hung Kao. (2016) Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism. PLOS ONE 11:9, pages e0162483.
Crossref
Crossref
Surya P Bhatt. (2016) Eosinophils in COPD: the Janus of phenotyping response to therapy?. The Lancet Respiratory Medicine 4:9, pages 681-683.
Crossref
Crossref
M. Miravitlles. (2016) Towards a patient-oriented treatment of COPD. Revista Portuguesa de Pneumologia (English Edition) 22:2, pages 73-74.
Crossref
Crossref
Patricia Hidalgo M, Carlos A Celis, Maria Ximena Rojas-Reyes & Rodolfo J Dennis. (2016) Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Gary P. Anderson. (2016) Advances in understanding COPD. F1000Research 5, pages 2392.
Crossref
Crossref
Linda Bryant. (2016) Nuggets of Knowledge: COPD – targeting the use of inhaled corticosteroids. Journal of Primary Health Care 8:1, pages 83.
Crossref
Crossref